Bevacizumab BS IV infusion 100mg “Nichi-Iko”, manufactured by Nichi-Iko, contains Bevacizumab (genetical recombination) [Bevacizumab follow-up 3]. This monoclonal antibody inhibits vascular endothelial growth factor A (VEGF-A), thereby blocking angiogenesis and limiting blood supply to tumors. It is supplied as 100mg in 4mL per bottle, with YJ code 4291461A1021.
Bevacizumab BS IV infusion 100mg “Nichi-Iko”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →